Contrast-enhanced magnetic resonance angiography: First-pass arterial enhancement as a function of gadolinium-chelate concentration, and the saline chaser volume and injection rate

Investigative Radiology

Volumn 47, Issue 2, 2012, Pages 121-127

  Husarik, Daniela B ^a   Bashir, Mustafa R ^b   Weber, Paul W ^c   Nichols, Eli B ^c   Howle, Laurens E ^c   Merkle, Elmar M ^b   Nelson, Rendon C ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Duke University   (United States)

Author keywords

contrast enhanced MR angiography; gadolinium based contrast agent; saline chaser

Indexed keywords

CONTRAST MEDIUM; GADOBENIC ACID; GADOLINIUM PENTETATE; GADOTERIDOL; SODIUM CHLORIDE;

AORTA; AREA UNDER THE CURVE; ARTICLE; CONTRAST ENHANCEMENT; FLOW KINETICS; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL;

EID: 84855837044     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3182300603     Document Type: Article

References (27)

1. Creasy JL, Price RR, Presbrey T, et al. Gadolinium-enhanced MR angiography. Radiology. 1990;175:280-283. (Pubitemid 20108584)
2. Prince MR, Yucel EK, Kaufman JA, et al. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging. 1993;3:877-881.
3. Hentsch A, Aschauer MA, Balzer JO, et al. Gadobutrol-enhanced movingtable magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography. Eur Radiol. 2003;13:2103-2114. (Pubitemid 37080744)
4. Willinek WA, von Falkenhausen M, Born M, et al. Noninvasive detection of steno-occlusive disease of the supra-aortic arteries with three-dimensional contrast-enhanced magnetic resonance angiography: a prospective, intraindividual comparative analysis with digital subtraction angiography. Stroke. 2005;36:38-43. (Pubitemid 40054172)
5. Anzidei M, Napoli A, Zaccagna F, et al. First-pass and high-resolution steady-state magnetic resonance angiography of the peripheral arteries with gadobenate dimeglumine: an assessment of feasibility and diagnostic performance. Invest Radiol. 2011;46:307-316.
6. Beranek-Chiu J, Froehlich JM, Wentz KU, et al. Improved vessel delineation in keyhole time-resolved contrast-enhanced MR angiography using a gadolinium doped flush. J Magn Reson Imaging. 2009;29:1147-1153.
7. Nael K, Krishnam M, Nael A, et al. Peripheral contrast-enhanced MR angiography at 3.0T, improved spatial resolution and low dose contrast: initial clinical experience. Eur Radiol. 2008;18:2893-2900.
8. Bhat H, Yang Q, Zuehlsdorff S, et al. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3 T using interleaved echo planar imaging. Invest Radiol. 2010;45:458-464.
9. Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology. 2007;245:168-175. (Pubitemid 47417800)
10. Habibi R, Krishnam MS, Lohan DG, et al. High-spatial-resolution lower extremity MR angiography at 3.0 T: contrast agent dose comparison study. Radiology. 2008;248:680-692.
11. Tomasian A, Salamon N, Lohan DG, et al. Supraaortic arteries: contrast material dose reduction at 3.0-T high-spatial-resolution MR angiography- feasibility study. Radiology. 2008;249:980-990.
12. Broome DR, Girguis MS, Baron PW, et al. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol. 2007;188:586-592. (Pubitemid 46167763)
13. Marckmann P, Skov L, Rossen K, et al. Case-control study of gadodiamiderelated nephrogenic systemic fibrosis. Nephrol Dial Transplant. 2007;22: 3174-3178. (Pubitemid 350202540)
14. Prince MR, Zhang H, Morris M, et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology. 2008;248:807-816.
15. Agarwal R, Brunelli SM, Williams K, et al. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. Nephrol Dial Transplant. 2009;24:856-863.
16. Pietsch H, Raschke M, Ellinger-Ziegelbauer H, et al. The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats. Invest Radiol. 2011;46:48-56.
17. Coursey CA, Nelson RC, Weber PW, et al. Contrast material administration protocols for 64-MDCT angiography: altering volume and rate and use of a saline chaser to better match the imaging window-physiologic phantom study. AJR Am J Roentgenol. 2009;193:1568-1575.
18. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model. Radiology. 1998;207: 647-655.
19. Maki JH, Prince MR, Chenevert TC. Optimizing three-dimensional gadolin-ium-enhanced magnetic resonance angiography. Original investigation. Invest Radiol. 1998;33:528-537. (Pubitemid 30261950)
20. Nikolaou K, Schoenberg SO, Brix G, et al. Quantification of pulmonary blood flow and volume in healthy volunteers by dynamic contrast-enhanced magnetic resonance imaging using a parallel imaging technique. Invest Radiol. 2004;39:537-545. (Pubitemid 39096771)
21. Tirkes AT, Rosen MA, Siegelman ES. Gadolinium susceptibility artifact causing false positive stenosis isolated to the proximal common carotid artery in 3D dynamic contrast medium enhanced MR angiography of the thorax-a brief review of causes and prevention. Int J Cardiovasc Imaging. 2003;19: 151-155. (Pubitemid 36456892)
22. Boos M, Lentschig M, Scheffler K, et al. Contrast-enhanced magnetic resonance angiography of peripheral vessels. Different contrast agent applications and sequence strategies: a review. Invest Radiol. 1998;33: 538-546. (Pubitemid 30261951)
23. Maki JH, Prince MR, Londy FJ, et al. The effects of time varying intravascular signal intensity and k-space acquisition order on three-dimensional MR angiography image quality. J Magn Reson Imaging. 1996;6:642-651. (Pubitemid 126701436)
24. Boos M, Scheffler K, Haselhorst R, et al. Arterial first pass gadolinium-CM dynamics as a function of several intravenous saline flush and Gd volumes. J Magn Reson Imaging. 2001;13:568-576. (Pubitemid 32231511)
25. Merkle EM, Dale BM, Barboriak DP. Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. Acad Radiol. 2007;14:795-803. (Pubitemid 46908778)
26. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724. (Pubitemid 41546838)
27. Kirchin MA, Pirovano GP, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol. 1998;33:798-809.